Latest Share Chat

REMOVE ADS

PureTech Regulatory News (PRTC)

PureTech Information

Share Price Information for PureTech (PRTC)

Share Price is delayed by 15 minutes

Get Live Data

124.40 -1.80 (-1.43%)

Bid:

124.00

Ask:

124.20

Spread: 0.20 (0.161%)

Market Cap: £302.81m

Last checked at -

Intraday PureTech Share Chart

REMOVE ADS

Transaction in Own Shares

19 Sep 2023 07:00

RNS Number : 8298M

PureTech Health PLC

19 September 2023

PureTech Health plc

Transaction in Own Shares

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

Date of purchase:	18 September 2023

Number of ordinary shares purchased:	13,710

Highest price paid per share:	223.00p

Lowest price paid per share:	222.50p

Volume weighted average price paid per share:	222.99p

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 14,509,661 ordinary shares in treasury and has 274,958,498 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 274,958,498 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that is expected to be filed soon for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points.

For more information, visit www.puretechhealth.com or connect with us on Twitter @puretechh.

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

Individual Transactions

Transaction Date	Transaction Time	Volume	Price (GBp)	Platform	Transaction Reference Number
18/09/2023	12:34:45	108	223	CHIX	00369566364TRLO0.1.1
18/09/2023	12:34:45	85	223	AQXE	00369566365TRLO0.1.1
18/09/2023	12:34:45	17	223	AQXE	00369566362TRLO0.1.1
18/09/2023	12:34:45	17	223	AQXE	00369566363TRLO0.1.1
18/09/2023	12:34:45	17	223	AQXE	00369566361TRLO0.1.1
18/09/2023	12:34:45	17	223	AQXE	00369566360TRLO0.1.1
18/09/2023	12:34:45	17	223	AQXE	00369566358TRLO0.1.1
18/09/2023	12:34:45	17	223	AQXE	00369566359TRLO0.1.1
18/09/2023	12:34:45	17	223	AQXE	00369566357TRLO0.1.1
18/09/2023	12:34:45	17	223	AQXE	00369566356TRLO0.1.1
18/09/2023	12:34:45	17	223	AQXE	00369566354TRLO0.1.1
18/09/2023	12:34:45	17	223	AQXE	00369566355TRLO0.1.1
18/09/2023	12:34:45	17	223	AQXE	00369566353TRLO0.1.1
18/09/2023	12:34:45	17	223	AQXE	00369566352TRLO0.1.1
18/09/2023	12:34:45	17	223	AQXE	00369566350TRLO0.1.1
18/09/2023	12:34:45	17	223	AQXE	00369566351TRLO0.1.1
18/09/2023	12:34:45	153	223	AQXE	00369566348TRLO0.1.1
18/09/2023	12:34:45	17	223	AQXE	00369566349TRLO0.1.1
18/09/2023	12:34:45	17	223	AQXE	00369566345TRLO0.1.1
18/09/2023	12:34:45	17	223	AQXE	00369566346TRLO0.1.1
18/09/2023	12:34:45	17	223	AQXE	00369566347TRLO0.1.1
18/09/2023	12:34:45	17	223	AQXE	00369566344TRLO0.1.1
18/09/2023	12:34:45	17	223	AQXE	00369566343TRLO0.1.1
18/09/2023	12:34:45	51	223	AQXE	00369566341TRLO0.1.1
18/09/2023	12:34:45	17	223	AQXE	00369566342TRLO0.1.1
18/09/2023	12:34:45	17	223	AQXE	00369566339TRLO0.1.1
18/09/2023	12:34:45	15	223	AQXE	00369566340TRLO0.1.1
18/09/2023	12:34:45	17	223	AQXE	00369566338TRLO0.1.1
18/09/2023	12:34:45	32	223	CHIX	00369566337TRLO0.1.1
18/09/2023	12:34:45	4	223	CHIX	00369566336TRLO0.1.1
18/09/2023	12:34:45	52	223	BATE	00369566335TRLO0.1.1
18/09/2023	12:34:45	36	223	CHIX	00369566334TRLO0.1.1
18/09/2023	12:34:45	36	223	CHIX	00369566332TRLO0.1.1
18/09/2023	12:34:45	36	223	CHIX	00369566333TRLO0.1.1
18/09/2023	12:34:45	36	223	CHIX	00369566331TRLO0.1.1
18/09/2023	12:34:45	324	223	CHIX	00369566329TRLO0.1.1
18/09/2023	12:34:45	36	223	CHIX	00369566330TRLO0.1.1
18/09/2023	12:34:45	36	223	CHIX	00369566328TRLO0.1.1
18/09/2023	12:34:45	36	223	CHIX	00369566327TRLO0.1.1
18/09/2023	12:34:45	36	223	CHIX	00369566326TRLO0.1.1
18/09/2023	12:34:45	52	223	BATE	00369566324TRLO0.1.1
18/09/2023	12:34:45	52	223	BATE	00369566325TRLO0.1.1
18/09/2023	12:34:45	52	223	BATE	00369566322TRLO0.1.1
18/09/2023	12:34:45	52	223	BATE	00369566323TRLO0.1.1
18/09/2023	12:34:45	36	223	CHIX	00369566320TRLO0.1.1
18/09/2023	12:34:45	52	223	BATE	00369566321TRLO0.1.1
18/09/2023	12:34:45	36	223	CHIX	00369566319TRLO0.1.1
18/09/2023	12:34:45	36	223	CHIX	00369566317TRLO0.1.1
18/09/2023	12:34:45	36	223	CHIX	00369566318TRLO0.1.1
18/09/2023	12:34:45	36	223	CHIX	00369566315TRLO0.1.1
18/09/2023	12:34:45	36	223	CHIX	00369566316TRLO0.1.1
18/09/2023	12:34:45	36	223	CHIX	00369566314TRLO0.1.1
18/09/2023	12:34:45	52	223	BATE	00369566312TRLO0.1.1
18/09/2023	12:34:45	36	223	CHIX	00369566313TRLO0.1.1
18/09/2023	12:34:45	9	223	TRQX	00369566311TRLO0.1.1
18/09/2023	12:34:45	9	223	TRQX	00369566310TRLO0.1.1
18/09/2023	12:34:45	9	223	TRQX	00369566308TRLO0.1.1
18/09/2023	12:34:45	9	223	TRQX	00369566309TRLO0.1.1
18/09/2023	12:34:45	9	223	TRQX	00369566306TRLO0.1.1
18/09/2023	12:34:45	9	223	TRQX	00369566307TRLO0.1.1
18/09/2023	12:34:45	9	223	TRQX	00369566305TRLO0.1.1
18/09/2023	12:34:45	9	223	TRQX	00369566304TRLO0.1.1
18/09/2023	12:34:45	9	223	TRQX	00369566302TRLO0.1.1
18/09/2023	12:34:45	9	223	TRQX	00369566303TRLO0.1.1
18/09/2023	12:34:45	9	223	TRQX	00369566301TRLO0.1.1
18/09/2023	12:34:45	9	223	TRQX	00369566299TRLO0.1.1
18/09/2023	12:34:45	9	223	TRQX	00369566300TRLO0.1.1
18/09/2023	12:34:45	9	223	TRQX	00369566298TRLO0.1.1
18/09/2023	12:34:45	9	223	TRQX	00369566297TRLO0.1.1
18/09/2023	12:34:45	9	223	TRQX	00369566296TRLO0.1.1
18/09/2023	12:34:45	9	223	TRQX	00369566295TRLO0.1.1
18/09/2023	12:34:45	52	223	BATE	00369566294TRLO0.1.1
18/09/2023	12:34:45	52	223	BATE	00369566293TRLO0.1.1
18/09/2023	12:34:45	52	223	BATE	00369566292TRLO0.1.1
18/09/2023	12:34:45	52	223	BATE	00369566291TRLO0.1.1
18/09/2023	12:34:45	52	223	BATE	00369566290TRLO0.1.1
18/09/2023	12:34:45	52	223	BATE	00369566289TRLO0.1.1
18/09/2023	12:34:45	52	223	BATE	00369566288TRLO0.1.1
18/09/2023	12:34:45	156	223	BATE	00369566287TRLO0.1.1
18/09/2023	12:34:45	52	223	BATE	00369566286TRLO0.1.1
18/09/2023	12:34:45	9	223	TRQX	00369566285TRLO0.1.1
18/09/2023	12:34:45	9	223	TRQX	00369566284TRLO0.1.1
18/09/2023	12:34:45	9	223	TRQX	00369566283TRLO0.1.1
18/09/2023	12:34:45	9	223	TRQX	00369566281TRLO0.1.1
18/09/2023	12:34:45	9	223	TRQX	00369566282TRLO0.1.1
18/09/2023	12:34:45	9	223	TRQX	00369566280TRLO0.1.1
18/09/2023	12:34:45	9	223	TRQX	00369566279TRLO0.1.1
18/09/2023	12:34:45	52	223	BATE	00369566277TRLO0.1.1
18/09/2023	12:34:45	52	223	BATE	00369566278TRLO0.1.1
18/09/2023	12:34:45	52	223	BATE	00369566276TRLO0.1.1
18/09/2023	12:34:45	52	223	BATE	00369566275TRLO0.1.1
18/09/2023	12:34:45	52	223	BATE	00369566274TRLO0.1.1
18/09/2023	12:34:45	52	223	BATE	00369566273TRLO0.1.1
18/09/2023	12:34:45	52	223	BATE	00369566272TRLO0.1.1
18/09/2023	12:34:45	52	223	BATE	00369566271TRLO0.1.1
18/09/2023	12:34:45	52	223	BATE	00369566270TRLO0.1.1
18/09/2023	12:34:45	9	223	TRQX	00369566269TRLO0.1.1
18/09/2023	12:34:45	45	223	TRQX	00369566268TRLO0.1.1
18/09/2023	12:34:45	36	223	CHIX	00369566266TRLO0.1.1
18/09/2023	12:34:45	36	223	CHIX	00369566267TRLO0.1.1
18/09/2023	12:34:45	36	223	CHIX	00369566265TRLO0.1.1
18/09/2023	12:34:45	36	223	CHIX	00369566264TRLO0.1.1
18/09/2023	12:34:45	144	223	CHIX	00369566263TRLO0.1.1
18/09/2023	12:34:45	36	223	CHIX	00369566262TRLO0.1.1
18/09/2023	12:34:45	36	223	CHIX	00369566261TRLO0.1.1
18/09/2023	12:34:45	36	223	CHIX	00369566260TRLO0.1.1
18/09/2023	12:34:45	54	223	BATE	00369566259TRLO0.1.1
18/09/2023	12:34:45	252	222.5	XLON	00369566258TRLO0.1.1
18/09/2023	12:34:45	229	223	XLON	00369566257TRLO0.1.1
18/09/2023	12:34:45	229	223	XLON	00369566256TRLO0.1.1
18/09/2023	12:34:45	1304	223	XLON	00369566255TRLO0.1.1
18/09/2023	12:34:45	229	223	XLON	00369566253TRLO0.1.1
18/09/2023	12:34:45	1673	223	XLON	00369566254TRLO0.1.1
18/09/2023	12:34:45	229	223	XLON	00369566252TRLO0.1.1
18/09/2023	12:34:45	229	223	XLON	00369566250TRLO0.1.1
18/09/2023	12:34:45	229	223	XLON	00369566251TRLO0.1.1
18/09/2023	12:34:45	22	223	XLON	00369566249TRLO0.1.1
18/09/2023	12:34:44	229	223	XLON	00369566246TRLO0.1.1
18/09/2023	12:34:44	229	223	XLON	00369566244TRLO0.1.1
18/09/2023	12:34:44	229	223	XLON	00369566245TRLO0.1.1
18/09/2023	12:34:44	229	223	XLON	00369566242TRLO0.1.1
18/09/2023	12:34:44	229	223	XLON	00369566243TRLO0.1.1
18/09/2023	12:34:44	229	223	XLON	00369566240TRLO0.1.1
18/09/2023	12:34:44	207	223	XLON	00369566241TRLO0.1.1
18/09/2023	12:34:44	229	223	XLON	00369566238TRLO0.1.1
18/09/2023	12:34:44	229	223	XLON	00369566239TRLO0.1.1
18/09/2023	12:34:44	229	223	XLON	00369566236TRLO0.1.1
18/09/2023	12:34:44	229	223	XLON	00369566237TRLO0.1.1
18/09/2023	12:34:44	114	223	XLON	00369566235TRLO0.1.1
18/09/2023	12:34:44	229	223	XLON	00369566234TRLO0.1.1
18/09/2023	12:34:44	229	223	XLON	00369566233TRLO0.1.1
18/09/2023	12:34:44	229	223	XLON	00369566232TRLO0.1.1
18/09/2023	12:34:44	916	223	XLON	00369566230TRLO0.1.1
18/09/2023	12:34:44	229	223	XLON	00369566231TRLO0.1.1
18/09/2023	12:34:44	115	223	XLON	00369566228TRLO0.1.1
18/09/2023	12:34:44	206	223	XLON	00369566229TRLO0.1.1
18/09/2023	12:34:44	229	223	XLON	00369566226TRLO0.1.1
18/09/2023	12:34:44	229	223	XLON	00369566227TRLO0.1.1

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSFLFFDADITLIV

Date		Source	Headline
4th Jun 2026	5:37 pm	RNS	Holding(s) in Company
29th May 2026	5:00 pm	RNS	Holding(s) in Company
27th May 2026	5:30 pm	RNS	Holding(s) in Company
22nd May 2026	5:00 pm	RNS	Holding(s) in Company
15th May 2026	7:00 am	RNS	Correction - Holding(s) in Company
13th May 2026	12:00 pm	RNS-R	PRTC To Showcase Deupirfenidone at ATS Conference
8th May 2026	7:00 am	RNS	Holding(s) in Company
7th May 2026	6:27 pm	RNS	Holding(s) in Company
1st May 2026	7:00 am	RNS	PureTech's Seaport Prices Upsized IPO Nasdaq: SPTX
29th Apr 2026	7:01 am	RNS	Final Results
29th Apr 2026	7:00 am	RNS	PRTC Voluntarily Delists Nasdaq Depositary Shares
27th Apr 2026	6:09 pm	RNS	Holding(s) in Company
27th Apr 2026	12:05 pm	RNS-R	PRTC's Seaport Adds Neuropsychiatry Veteran to BOD
24th Apr 2026	5:58 pm	RNS	Holding(s) in Company
22nd Apr 2026	12:00 pm	RNS-R	PRTC's Gallop: Positive Ph1 Topline MDS & AML Data
16th Apr 2026	5:00 pm	RNS	Holding(s) in Company
16th Apr 2026	7:00 am	RNS	Holding(s) in Company
13th Apr 2026	7:05 am	RNS	Notice of Results
13th Apr 2026	7:00 am	RNS	PRTC's Seaport Files for Proposed Nasdaq IPO
1st Apr 2026	7:00 am	RNS	Total Voting Rights
25th Mar 2026	6:00 pm	RNS-R	PRTC’s Seaport: GlyphAllo Paper Published
13th Mar 2026	4:35 pm	RNS	PDMR Notification RSU Vesting
2nd Mar 2026	7:00 am	RNS	Total Voting Rights
25th Feb 2026	7:00 am	RNS-R	PRTC to Present at Leerink Healthcare Conference
19th Feb 2026	5:15 pm	RNS-R	PRTC's Deupirfenidone Granted FDA & EU ODD for IPF
6th Jan 2026	12:00 pm	RNS-R	PureTech to Present at the JP Morgan Conference
18th Dec 2025	7:00 am	RNS	PureTech Appoints Robert Lyne as CEO
10th Dec 2025	5:41 pm	RNS	Results of AGM on June 16, 2025 – Update Statement
10th Dec 2025	5:30 pm	RNS	Holding(s) in Company
8th Dec 2025	7:00 am	RNS-R	PRTC: Successful FDA Meeting; IPF Phase 3 in 1H26
5th Dec 2025	6:00 pm	RNS-R	PRTC's Gallop: Positive Initial Topline AML Data
18th Nov 2025	5:30 pm	RNS	Holding(s) in Company
7th Nov 2025	6:18 pm	RNS	Holding(s) in Company
3rd Nov 2025	2:00 pm	RNS-R	PRTC: New LYT-200 AML Data + Update at ASH
22nd Oct 2025	7:00 am	RNS-R	PRTC: New IPF Data Show Benefit in Older Patients
17th Oct 2025	5:30 pm	RNS	Holding(s) in Company
14th Oct 2025	7:00 am	RNS	Holding(s) in Company
10th Oct 2025	5:59 pm	RNS	Holding(s) in Company
9th Oct 2025	6:10 pm	RNS	Holding(s) in Company
1st Oct 2025	7:00 am	RNS	Holding(s) in Company
29th Sep 2025	7:00 am	RNS-R	PRTC: New IPF Data Show Switch Patients Stabilized
24th Sep 2025	7:00 am	RNS	PDMR DEALING - PURCHASE OF SHARES
23rd Sep 2025	5:30 pm	RNS	Holding(s) in Company
19th Sep 2025	5:52 pm	RNS	Holding(s) in Company
19th Sep 2025	7:00 am	RNS	Holding(s) in Company
11th Sep 2025	12:05 pm	RNS-R	PRTC's Seaport Advances 2nd Candidate Into Clinic
4th Sep 2025	5:30 pm	RNS	Holding(s) in Company
1st Sep 2025	7:00 am	RNS	Total Voting Rights
28th Aug 2025	7:00 am	RNS	Half-year Report
21st Aug 2025	12:00 pm	RNS-R	PureTech Showcases Differentiated IPF Strategy

Latest Share Chat

PureTech Regulatory News (PRTC)

Share Price Information for PureTech (PRTC)

Intraday PureTech Share Chart

Transaction in Own Shares

Please enter at least 2 characters

No results found

Search results

Recently viewed

Trending